Related Experiment Videos

Statin adherence and mortality in patients enrolled in a secondary prevention program

Brandy D McGinnis1, Kari L Olson, Thomas M A Delate

  • 1Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO 80011, USA. brandy.d.mcginnis@kp.org

The American Journal of Managed Care
|October 23, 2009
PubMed

Insights

High statin adherence (proportion of days covered >80%) significantly reduces mortality risk in cardiovascular patients. Improving statin adherence is crucial for secondary disease prevention and better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Public Health

Background:

  • Secondary prevention programs aim to reduce recurrent cardiovascular events.
  • Statin therapy is a cornerstone of cardiovascular disease management.
  • Patient adherence to long-term medication regimens can be challenging.

Purpose of the Study:

  • To assess statin adherence rates in patients within a secondary cardiovascular disease prevention program.
  • To determine the impact of statin adherence on subsequent clinical events, including mortality and recurrent cardiac events.

Main Methods:

  • A cohort of 2201 patients with a prior cardiac event initiating statin therapy was followed.
  • Statin adherence was measured by proportion of days covered (PDC), dichotomized at >80% and <=80%.
  • Cox proportional hazards models analyzed the association between PDC and clinical outcomes.

Main Results:

  • Overall 3-year PDC was 75.4%.
  • Adherence >80% was associated with a 56% lower risk of all-cause death (adjusted HR=0.44).
  • Adherence >80% showed a trend towards reduced risk for combined death/recurrent cardiac events (HR=0.75).

Conclusions:

  • Statin nonadherence remains linked to increased mortality in high-risk cardiovascular patients.
  • Achieving higher statin adherence (PDC >80%) is vital for improving survival in secondary prevention.
  • Continued efforts are necessary to enhance medication adherence in this population.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...